BMO Capital Adjusts Price Target on Willis Towers Watson Public to $332 From $365, Keeps Outperform Rating
BMO Capital reduced its price target for Willis Towers Watson Public from $365 to $332, maintaining an outperform rating. The company's stock closed at $288.23, reflecting a 3.60% decrease over the past year.
How this was made
The 30-second read
Why it matters
The downgrade may prompt short‑term sell pressure, but the Outperform rating still suggests the stock could outperform peers if fundamentals improve.
Market read
Analyst target cuts are a common catalyst for short‑term price moves; traders may adjust positions accordingly.
What to watch
Potential upside from upcoming contract wins or cost‑saving initiatives not reflected in the target.
Background
BMO Capital provides composite ratings based on valuation, EPS revisions, and visibility. The firm adjusted its outlook for Willis Towers Watson, reflecting a more cautious view.
Ticker impact
BMO Capital lowered its price target for Willis Towers Watson to $332 from $365 and kept an Outperform rating.
likely downward pressure as the market prices in the reduced target.
Target reduction signals weaker expectations; investors may trim exposure.
Market effects
May affect other insurance and consulting peers as analysts reassess valuation multiples.
Limited to U.S. listed insurers; no broader regional effect.
Minimal global impact beyond sector peers.
Counterpoint
Some investors may view the target cut as an overreaction and see buying opportunity at current levels.
Key entities
- companyWillis Towers Watson
Global advisory, broking and solutions company.
- analystBMO Capital
Research arm of BMO Financial Group.
